News
Zacks Investment Research on MSN1d
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback